Avaxia Biologics Receives Phase I SBIR Grant
Avaxia Biologics has been awarded a phase I SBIR grant from the National Institute of Dental and Craniofacial Research to support the development of a novel antibody therapeutic
The Liverpool School of Tropical Medicine (LSTM) in the UK has opened a £20m ($23.2m) robotic AI laboratory to test drugs and vaccines against infections and diseases.
Ozonics International has announced that a study exploring the healing of diabetic skin ulcers using topical oxygen/ozone gas mixtures could not proceed to completion and was now abandoned.